Published in J Immunol on January 27, 2010
Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build. Cell Mol Life Sci (2013) 2.14
Advances in tenascin-C biology. Cell Mol Life Sci (2011) 1.50
Tenascin-C drives persistence of organ fibrosis. Nat Commun (2016) 1.41
Tenascins and the importance of adhesion modulation. Cold Spring Harb Perspect Biol (2011) 1.29
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Front Immunol (2015) 1.12
Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis. J Leukoc Biol (2010) 1.09
Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages. Sci Signal (2016) 1.05
Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155. Cell Rep (2012) 1.04
Toll like receptor signaling in "inflammaging": microRNA as new players. Immun Ageing (2013) 0.99
VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice. Am J Physiol Lung Cell Mol Physiol (2013) 0.96
Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition. Matrix Biol (2012) 0.92
Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage. BMC Musculoskelet Disord (2011) 0.91
Extracellular matrix regulation of inflammation in the healthy and injured spinal cord. Exp Neurol (2014) 0.89
FosB regulates stretch-induced expression of extracellular matrix proteins in smooth muscle. Am J Pathol (2011) 0.89
Inflammation in joint injury and post-traumatic osteoarthritis. Osteoarthritis Cartilage (2015) 0.87
Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system. Front Physiol (2014) 0.86
Spinal toll-like receptor signaling and nociceptive processing: regulatory balance between TIRAP and TRIF cascades mediated by TNF and IFNβ. Pain (2013) 0.86
Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity. J Clin Endocrinol Metab (2012) 0.85
Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis. Ann Rheum Dis (2015) 0.85
Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression. Trends Cancer Res (2013) 0.85
Tenascin-C expression is associated with poor prognosis in hepatocellular carcinoma (HCC) patients and the inflammatory cytokine TNF-α-induced TNC expression promotes migration in HCC cells. Am J Cancer Res (2015) 0.83
Tenascin-C: a novel mediator of hepatic ischemia and reperfusion injury. Hepatology (2011) 0.83
Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis. Br J Pharmacol (2011) 0.83
Tenascin-C: Form versus function. Cell Adh Migr (2015) 0.83
Tenascins in fibrotic disorders-from bench to bedside. Cell Adh Migr (2015) 0.81
Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res Ther (2012) 0.80
Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiation. J Am Heart Assoc (2014) 0.79
Biological Markers for Pulpal Inflammation: A Systematic Review. PLoS One (2016) 0.78
Post-traumatic arthritis: overview on pathogenic mechanisms and role of inflammation. RMD Open (2016) 0.76
Early remodelling of the extracellular matrix proteins tenascin-C and phosphacan in retina and optic nerve of an experimental autoimmune glaucoma model. J Cell Mol Med (2016) 0.75
High tenascin-C levels cause inadequate myocardial blush grade in patients with acute myocardial infarction. Int J Clin Exp Med (2015) 0.75
Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study. Arthritis Res Ther (2015) 0.75
Gene expression profile of pulpitis. Genes Immun (2016) 0.75
Bartonella quintana lipopolysaccharide (LPS): structure and characteristics of a potent TLR4 antagonist for in-vitro and in-vivo applications. Sci Rep (2016) 0.75
Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis. RMD Open (2016) 0.75
Gene expression profiling of macrophages: implications for an immunosuppressive effect of dissolucytotic gold ions. J Inflamm (Lond) (2012) 0.75
Tenascin-C Signaling in melanoma. Cell Adh Migr (2015) 0.75
Carbon Monoxide Inhibits Tenascin-C Mediated Inflammation via IL-10 Expression in a Septic Mouse Model. Mediators Inflamm (2015) 0.75
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol (2011) 5.11
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med (2009) 3.87
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med (2009) 2.15
Quantitative high-throughput analysis of transcription factor binding specificities. Nucleic Acids Res (2004) 1.87
Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet (2002) 1.76
Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-κB family DNA binding. Nat Immunol (2011) 1.72
The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal (2009) 1.72
Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair (2011) 1.41
Extensive characterization of NF-κB binding uncovers non-canonical motifs and advances the interpretation of genetic functional traits. Genome Biol (2011) 1.40
Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) (2011) 1.29
Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages. J Immunol (2002) 1.29
The role of transposable elements in the regulation of IFN-lambda1 gene expression. Proc Natl Acad Sci U S A (2009) 1.24
Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients. Scand J Infect Dis (2006) 1.20
Localization of a long-range cis-regulatory element of IL13 by allelic transcript ratio mapping. Genome Res (2006) 1.16
IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood (2010) 1.15
Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155. Cell Rep (2012) 1.04
Expression and immune function of tenascin-C. Crit Rev Immunol (2011) 1.04
Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target. Proc Natl Acad Sci U S A (2013) 1.03
Self-assembled monolayers of alpha,omega-diphosphonic acids on Ti enable complete or spatially controlled surface derivatization. Langmuir (2004) 0.97
The alarmin IL-33 is a notch target in quiescent endothelial cells. Am J Pathol (2012) 0.94
Context-specific functional effects of IFNGR1 promoter polymorphism. Hum Mol Genet (2006) 0.91
Endogenous activation of adaptive immunity: tenascin-C drives interleukin-17 synthesis in murine arthritic joint disease. Arthritis Rheum (2012) 0.89
Evolution of vertebrate immunity: sequence and functional analysis of the SEFIR domain family member Act1. J Mol Evol (2011) 0.88
Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 0.85
Cryptic domains of tenascin-C differentially control fibronectin fibrillogenesis. Matrix Biol (2010) 0.85
FOXO3 as a new IKK-ε-controlled check-point of regulation of IFN-β expression. Eur J Immunol (2012) 0.84
Comparing the fine specificity of DNA binding by NF-kappaB p50 and p52 using principal coordinates analysis. Nucleic Acids Res (2003) 0.83
Tenascin-C: Form versus function. Cell Adh Migr (2015) 0.83
Beyond the enhanceosome: cluster of novel κB sites downstream of the human IFN-β gene is essential for lipopolysaccharide-induced gene activation. Blood (2010) 0.82
Isometric contraction of Dupuytren's myofibroblasts is inhibited by blocking intercellular junctions. J Invest Dermatol (2013) 0.82
Identification of novel and distinct binding sites within tenascin-C for soluble and fibrillar fibronectin. J Biol Chem (2011) 0.82
Quantitative profiling of protein-DNA binding on microarrays. Methods Mol Biol (2006) 0.80
Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res Ther (2012) 0.80
Cross-species analysis reveals evolving and conserved features of the nuclear factor κB (NF-κB) proteins. J Biol Chem (2013) 0.80
IL-17 receptor adaptor protein Act1/CIKS plays an evolutionarily conserved role in antiviral signaling. J Immunol (2012) 0.77
Activation and function of interferon regulatory factor 5. J Interferon Cytokine Res (2014) 0.77
Functional conservation of Rel binding sites in drosophilid genomes. Genome Res (2007) 0.76
Illustrating the interplay between the extracellular matrix and microRNAs. Int J Exp Pathol (2014) 0.76
Detecting and modulating the NF-kB activity in human immune cells: generation of human cell lines with altered levels of NF-kappaB. Methods Mol Biol (2009) 0.75
Quantitative measurement of cytokine expression in synoviocytes derived from rheumatoid arthritis patients. Methods Mol Biol (2009) 0.75